Concepedia

Jens Opitz

JO

Statistics

Publications

6

Citations

309

H-Index

6

Active since

1998

Affiliations

Fresenius (Germany)(Current)

Neu-Ulm University of Applied Sciences

Fresenius Kabi (Czechia)

Jens Opitz is an author at Fresenius (Germany) specializing in medicine, starch physicochemical properties, and pharmacy.

Publications per year

1998–2003

6

Publications

6

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

J. Waitzinger, Frank Bepperling, G nther Pabst et al. · Clinical Drug Investigation · 1998 · 108 citations

, , +10

Hydroxyethyl Starch (HES) [130/0.4],??? a New HES Specification

J. Waitzinger, Frank Bepperling, G nther Pabst et al. · Drugs in R&D · 2003 · 85 citations

, , +3

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

J Leuschner, Jens Opitz, Andreas Winkler et al. · Drugs in R&D · 2003 · 66 citations

, , +4

Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers

J. Waitzinger, Frank Bepperling, G nther Pabst et al. · Clinical Drug Investigation · 1999 · 27 citations

, , +4

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers

Frank Bepperling, Jens Opitz, J. Waitzinger et al. · Critical Care · 1999 · 12 citations · Full text

, , +8

1–5 of 6